Research study Program year 2025 Source: CMS Open Payments

Nn9535-4801

Research payments

$4,329,996

24,271 payments

Through program year 2025, $4,329,996 in research payments was reported against Nn9535-4801, across 24,271 payments.

Paid by (largest first)
Novo Nordisk AS; Novo Nordisk Inc
ClinicalTrials.gov
No trial number was reported for this study

By program year

4 rows
Year Kind Amount Payments
2025 Research $658,829 300
2024 Research $1,667,006 8,836
2023 Research $1,701,103 8,026
2022 Research $303,057 7,109

Breakdown

Who paid Research payments · program years 2022–2025
  1. Novo Nordisk AS $4,304,000 24,085 payments
  2. Novo Nordisk Inc $25,996 186 payments
Who received the money Research payments · program years 2022–2025
  1. Encore Medical Research, LLC Organisation paid for research $195,702 476 payments
  2. Accellacare Organisation paid for research $184,150 703 payments
  3. Cedar Crosse Research Center Organisation paid for research $168,323 987 payments
  4. Velocitycare Westlake Organisation paid for research $151,369 706 payments
  5. Joslin Diabetes Center Organisation paid for research $149,215 495 payments
  6. Valley Clinical Trials Organisation paid for research $135,169 322 payments
  7. Valley Research Organisation paid for research $131,484 263 payments
  8. Northern Pines Health Center, Pc Organisation paid for research $124,186 372 payments
  9. Wetlin Research Associates Organisation paid for research $122,076 520 payments
  10. First Valley Medical Group Organisation paid for research $120,726 764 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record